The role of late reperfusion in ST-segment elevation myocardial infarction: a real-world retrospective cohort study.

ABSTRACT: Background:Early reperfusion of the coronary artery has become the first choice for patients with ST-segment elevation myocardial infarction (STEMI). How to deal with patients who miss the time window for early reperfusion is still controversial. Based on real-world data, this study was conducted to explore whether percutaneous coronary intervention (PCI) has an advantage over standard drug therapy in patients who miss the optimal treatment window.

Methods:Consecutive patients who were diagnosed with STEMI and met the inclusion criteria between 2009 and 2018 in our center were retrospectively included in this cohort study. The primary endpoint events were major adverse cardiac events (MACEs), including heart failure, sudden cardiac death, malignant arrhythmia, thrombi

SUBMITTER: Guo Q 

PROVIDER: S-EPMC7189551 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature